SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001193125-24-154766 from Karyopharm Therapeutics Inc. (KPTI) (CIK 0001503802) (KPTI)

Karyopharm Therapeutics Inc. (KPTI) (CIK 0001503802)
Date: June 5, 2024 · CIK: 0001503802 · Accession: 0001193125-24-154766

AI Filing Summary & Sentiment

File numbers found in text: 333-279833

Date
June 5, 2024
Author
Not clearly detected
Form
CORRESP
Company
Karyopharm Therapeutics Inc. (KPTI) (CIK 0001503802)

Letter

Re: Karyopharm Therapeutics Inc.

June 5, 2024

VIA EDGAR SUBMISSION

Securities and Exchange Commission

Division of Corporation Finance, Office of Life Sciences

100 F Street, NE

Washington, DC 20549

Attention: Chris Edwards

Registration Statement on Form S-3

Filed May 30, 2024

File No. 333-279833

Request for Acceleration

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Karyopharm Therapeutics Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333- 279833), so that it may become effective at 4:30 p.m., Eastern Time, on June 7, 2024, or as soon as practicable thereafter, or at such later time as the Registrant or its counsel may orally request via telephone call to the staff.

Very truly yours,
KARYOPHARM THERAPEUTICS INC.

Show Raw Text
CORRESP
1
filename1.htm

CORRESP

 June 5, 2024

VIA EDGAR SUBMISSION

 Securities and Exchange
Commission

 Division of Corporation Finance, Office of Life Sciences

100 F Street, NE

 Washington, DC 20549

Attention: Chris Edwards

Re:
 Karyopharm Therapeutics Inc.

Registration Statement on Form S-3

Filed May 30, 2024

 File No. 333-279833

 Request for Acceleration

Ladies and Gentlemen:

 Pursuant to Rule 461 under the Securities
Act of 1933, as amended, Karyopharm Therapeutics Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333- 279833), so
that it may become effective at 4:30 p.m., Eastern Time, on June 7, 2024, or as soon as practicable thereafter, or at such later time as the Registrant or its counsel may orally request via telephone call to the staff.

 Very truly yours,

KARYOPHARM THERAPEUTICS INC.

By:

/s/ Michael Mano

Name:

Michael Mano

Title:

Senior Vice President, General Counsel and Secretary

cc:
 Jason Kropp, Wilmer Cutler Pickering Hale and Dorr LLP

Craig Hilts, Wilmer Cutler Pickering Hale and Dorr LLP